Why is Jubilant Pharmo falling/rising?

As of 17-Jul, Jubilant Pharmova Ltd's stock price is currently at 1,202.00, reflecting an increase of 3.0 (0.25%). The stock has been gaining for the last two days, with a return of 0.41% during this period. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Over the past week, the stock has risen by 2.85%, significantly outperforming the Sensex, which has declined by 1.12%. The company has reported strong financial performance, including a 25.02% growth in operating profit and positive results for the last seven consecutive quarters. However, there are concerns regarding falling investor participation, as the delivery volume has decreased by 30.17% compared to the 5-day average.
In the broader market context, Jubilant Pharmova's performance has been impressive, with a year-to-date return of 8.68%, compared to the Sensex's 5.27%. This strong performance is supported by high institutional holdings at 24.27%, which suggests confidence from more sophisticated investors. Despite the positive short-term and long-term returns, there are risks associated with the company's poor long-term growth, as net sales and operating profit have shown declines over the past five years. Overall, the stock's recent upward movement can be attributed to its strong financial results and favorable comparisons to the benchmark, despite some underlying concerns regarding its long-term growth trajectory.